133
Views
8
CrossRef citations to date
0
Altmetric
Review

Molecular variants and mutations in medulloblastoma

&
Pages 43-51 | Published online: 04 Feb 2014

References

  • PuiCHGajjarAJKaneJRQaddoumiIAPappoASChallenging issues in pediatric oncologyNat Rev Clin Oncol2011854054921709698
  • SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin201262102922237781
  • GajjarAChintagumpalaMAshleyDRisk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialLancet Oncol2006781382017012043
  • GururanganSKrauserJWatralMAEfficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastomaNeuro Oncol20081074575118755919
  • RutkowskiSvon HoffKEmserASurvival and prognostic factors of early childhood medulloblastoma: an international meta-analysisJ Clin Oncol2010284961496820940197
  • PackerRJGoldweinJNicholsonHSTreatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children’s Cancer Group StudyJ Clin Oncol1999172127213610561268
  • NorthcottPAKorshunovAWittHMedulloblastoma comprises four distinct molecular variantsJ Clin Oncol2011291408141420823417
  • TaylorMDNorthcottPAKorshunovAMolecular subgroups of medulloblastoma: the current consensusActa Neuropathol201212346547222134537
  • DolecekTAProppJMStroupNEKruchkoCCBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009Neuro Oncol201214Suppl 5v1v4923095881
  • PackerRJCogenPVezinaGRorkeLBMedulloblastoma: clinical and biologic aspectsNeuro Oncol1999123225011550316
  • TaylorMDMainprizeTGRutkaJTMolecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a reviewNeurosurgery20004788890111014429
  • EvansGBurnellLCampbellRGattamaneniHRBirchJCongenital anomalies and genetic syndromes in 173 cases of medulloblastomaMed Pediatr Oncol1993214334348515724
  • LouisDNOhgakiHWiestlerODThe 2007 WHO classification of tumours of the central nervous systemActa Neuropathol20071149710917618441
  • McManamyCSPearsJWestonCLNodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behaviorBrain Pathol20071715116417388946
  • MassiminoMAntonelliMGandolaLHistological variants of medulloblastoma are the most powerful clinical prognostic indicatorsPediatr Blood Cancer20136021021622693015
  • EllisonDWChildhood medulloblastoma: novel approaches to the classification of a heterogeneous diseaseActa Neuropathol201012030531620652577
  • RodriguezFJEberhartCO’NeillBPHistopathologic grading of adult medulloblastomasCancer20071092557256517487854
  • EvansDGFarndonPABurnellLDGattamaneniHRBirchJMThe incidence of Gorlin syndrome in 173 consecutive cases of medulloblastomaBr J Cancer1991649599611931625
  • FarndonPADel MastroRGEvansDGKilpatrickMWLocation of gene for Gorlin syndromeLancet19923395815821347096
  • GilbertsonRJMedulloblastoma: signalling a change in treatmentLancet Oncol2004520921815050952
  • SkomorowskiMTaxierMWiseWJrTurcot syndrome type 2: medulloblastoma with multiple colorectal adenomasClin Gastroenterol Hepatol201210A2422732270
  • GururanganSFrankelWBroaddusRMultifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutationNeuro Oncol200810939717993636
  • TaboriUBaskinBShagoMUniversal poor survival in children with medulloblastoma harboring somatic TP53 mutationsJ Clin Oncol2010281345135020142599
  • PeiYMooreCEWangJAn animal model of MYC-driven medulloblastomaCancer Cell20122115516722340590
  • RauschTJonesDTZapatkaMGenome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutationsCell2012148597122265402
  • ZhukovaNRamaswamyVRemkeMSubgroup-specific prognostic implications of TP53 mutation in medulloblastomaJ Clin Oncol2013312927293523835706
  • NorthcottPAJonesDTKoolMMedulloblastomics: the end of the beginningNat Rev Cancer20121281883423175120
  • KoolMKosterJBuntJIntegrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological featuresPLoS One20083e308818769486
  • HuseJTHollandECTargeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastomaNat Rev Cancer20101031933120414201
  • KoolMKorshunovARemkeMMolecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasActa Neuropathol201212347348422358457
  • NorthcottPAKorshunovAPfisterSMTaylorMDThe clinical implications of medulloblastoma subgroupsNat Rev Neurol2012834035122565209
  • ParsonsDWLiMZhangXThe genetic landscape of the childhood cancer medulloblastomaScience201133143543921163964
  • PughTJWeeraratneSDArcherTCMedulloblastoma exome sequencing uncovers subtype-specific somatic mutationsNature201248810611022820256
  • Bien-WillnerGALopez-TerradaDBhattacharjeeMBEarly recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangementNeuro Oncol20121483184022573308
  • BarboutiAStankiewiczPNusbaumCThe breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeatsAm J Hum Genet20047411014666446
  • MinHSLeeJYKimSKParkSHGenetic grouping of medulloblastomas by representative markers in pathologic diagnosisTransl Oncol2013626527223730405
  • EllisonDWKocakMDaltonJDefinition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variablesJ Clin Oncol2011291400140720921458
  • EllisonDWDaltonJKocakMMedulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsActa Neuropathol201112138139621267586
  • NorthcottPAShihDJPeacockJSubgroup-specific structural variation across 1,000 medulloblastoma genomesNature2012488495622832581
  • JonesDTJagerNKoolMDissecting the genomic complexity underlying medulloblastomaNature201248810010522832583
  • GibsonPTongYRobinsonGSubtypes of medulloblastoma have distinct developmental originsNature20104681095109921150899
  • RobinsonGParkerMKranenburgTANovel mutations target distinct subgroups of medulloblastomaNature2012488434822722829
  • PomeroySLTamayoPGaasenbeekMPrediction of central nervous system embryonal tumour outcome based on gene expressionNature200241543644211807556
  • TaylorMDLiuLRaffelCMutations in SUFU predispose to medulloblastomaNat Genet20023130631012068298
  • NorthcottPANakaharaYWuXMultiple recurrent genetic events converge on control of histone lysine methylation in medulloblastomaNat Genet20094146547219270706
  • NorthcottPAHielscherTDubucAPediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinctActa Neuropathol201112223124021681522
  • HattonBAVillavicencioEHTsuchiyaKDThe Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spreadCancer Res2008681768177618339857
  • GajjarAStewartCFEllisonDWPhase I study of vismodegib in children with recurrent or refractory medulloblastoma: a Pediatric Brain Tumor Consortium StudyClin Cancer Res10242013 [Epub ahead of print.]
  • GajjarAGururanganSQaddoumiIA prospective phase II study to determine the efficacy of GDC 0449 (vismodegib)in adults with recurrent medulloblastoma (MB): a Pediatric Brain Tumor Consortium Study (PBTC 25B)Proc Am Soc Clin Oncol2013312035
  • YauchRLDijkgraafGJAlickeBSmoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastomaScience200932657257419726788
  • DijkgraafGJAlickeBWeinmannLSmall molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistanceCancer Res20117143544421123452
  • BuonamiciSWilliamsJMorrisseyMInterfering with resistance to smoothened antagonists by inhibition of the Pi3K pathway in medulloblastomaSci Transl Med2010218
  • KawauchiDRobinsonGUzielTA mouse model of the most aggressive subgroup of human medulloblastomaCancer Cell20122116818022340591
  • GajjarAJHeidemanRLDouglassECRelation of tumor-cell ploidy to survival in children with medulloblastomaJ Clin Oncol199311221122178229136
  • SwartlingFJSavovVPerssonAIDistinct neural stem cell populations give rise to disparate brain tumors in response to N-MYCCancer Cell20122160161322624711
  • RamaswamyVRemkeMBouffetERecurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisLancet Oncol2013141200120724140199
  • KimuraHNgJMYCurranTTransient inhibition of the hedgehog pathway in young mice causes permanent defects in bone structureCancer Cell20081324926018328428
  • SanaiNBuyllaAABergerMSNeural stem cells and the origin of gliomasN Engl J Med200535381182216120861